BASF to sell omega-3 manufacturing facility in Brattvag, Norway

6:30 AM, 22nd November 2014

LUDWIGSHAFEN, GERMANY/MOUNT BETHEL, US: BASF has signed a definitive agreement to sell its manufacturing facility for natural fish oils, medium-concentrated omega-3s, and customized bottled fish oil in Brattvag, Norway, to Marine Ingredients, a leading manufacturer of quality marine-based ingredients and customized products. Both parties agreed not to disclose financial details of the transaction, which is expected to be closed in first quarter of 2015.

As part of the agreement, the 47 employees currently working in Brattvag will transfer from BASF to Marine Ingredients. With the acquisition, Marine Ingredients will gain control of omega-3 production, which is central to its business, thus expanding its ability to serve customers with tailor-made omega-3 products.

0 Comments

Your Comments (Up to 2000 characters)

Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Submit

BROOKINGS, US: Qi Hua Fan, Associate Professor, South Dakota State University, set out to make a less expensive supercapacitor for storing renewable e ...

Paper based electronic sensors for medical tools

WASHINGTON DC, US: Flexible electronic sensors based on paper - an inexpensive material - have the potential to cut the price of a wide range of medic ...

Givaudan opens expanded technical centre, regional offices in Dubai

DUBAI, UAE: Givaudan, the world’s leading Flavour and Fragrance company, opened its new, expanded technical centre and regional offices in Dubai ...

Ineos plans to invest $1.0 billion in Britain’s shale gas industry

LONDON, UK: Swiss-based petrochemical firm Ineos launched plans to become the biggest player in Britain’s fracking sector with a $1.0-billion in ...

Bayer opens Weed Resistance Competence Center in Frankfurt, Germany

FRANKFURT, MAIN/GERMANY: Bayer CropScience opened Weed Resistance Competence Center (WRCC) in Frankfurt, Germany on 19 November 2014. This is a major ...

Sunshine Biopharma, Lonza to manufacture anti-cancer drug

MONTREAL, CANADA: Sunshine Biopharma Inc, a pharmaceutical company focused on the research, development and commercialization of drugs for the treatme ...